Anzeige
Mehr »
Login
Samstag, 27.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Geheimtipp: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Business Wire-Archiv vom 20.12.2018

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
20.12.18ESI Will Be at CES 2019234Accelerating Manufacturing Engineering Developments for the Future of E-mobility ESI Group (Paris:ESI), leading innovator in Virtual Prototyping software and services for manufacturing...
► Artikel lesen
20.12.18Announcement from Natuzzi S.p.A.399Natuzzi S.p.A. (the "Company") announces that, subject to obtaining any applicable authorizations, the Company, along with the Trade Unions and Italian relevant authorities agreed to extend...
► Artikel lesen
20.12.18Nexa Resources S.A. Announces That the Installation License for Its Aripuana Greenfield Project Was Granted133Nexa Resources S.A. (NYSE: NEXA) (TSX:NEXA)("Nexa Resources" or the "Company") announces that the Environmental Authority of the State of Mato Grosso, Brazil (SEMA/MT) granted today the Installation...
► Artikel lesen
20.12.18Zynga Enters Into Agreement to Acquire Small Giant Games, Creator of Hit Mobile Game Franchise Empires & Puzzles207Adds a Proven Studio, Another Forever Franchise and Expands New Game Pipeline Acquisition Expected to Close Effective as of January 1, 2019 Zynga Raises Q4 2018...
► Artikel lesen
20.12.18Gecina Invests in Paris Fonds Vert199Regulatory News: In line with the acceleration of its innovation policy, Gecina (Paris:GFC) has signed an agreement to invest 5 million euros in the regional investment fund "Paris...
► Artikel lesen
20.12.18Results of the Phase I Study of Repeated and Increasing Doses to Assess CER-209 in NASH/NAFLD69Absence of any major adverse events, confirming CER-209's favorable safety and tolerance profile Daily administration of increasing doses of CER-209 over a 28-day period in patients...
► Artikel lesen
20.12.18AM Best Affirms Credit Ratings of Hannover Rueck SE and Its Main Subsidiaries179AM Best has affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term Issuer Credit Rating (Long-Term ICR) of "aa" of Hannover Rueck SE (Hannover Re) (Germany) and its...
► Artikel lesen
20.12.18Soundreef: Gericht in Rom verweist die Sache SIAE / Soundreef an den Europäischen Gerichtshof69Erklärung von Soundreef: Die SIAE (Italienische Gesellschaft der Autoren und Verleger), die Agentur, die früher die Wahrnehmung der Urheberrechte an Kompositionen in Italien kontrollierte...
► Artikel lesen
20.12.18Onxeo Announces its Financial Agenda for 2019108Regulatory News: Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO FR0010095596), a clinical-stage biotechnology company specializing in the development of innovative drugs in...
► Artikel lesen
20.12.18Customer Experience Management: Importance and Steps to Improve Customer Engagement53A leading customer analytics solutions provider, Quantzig, has announced the completion of their latest article on theimportance of customer experience management and how companies can improve...
► Artikel lesen
20.12.18Global Telehandlers Market for the Construction Industry 2019-2023 | Key Factors Driving Growth | Technavio191Technavio analysts forecast the global telehandlers market for the construction industry to grow at a CAGR of nearly 6% during the forecast period, according to their latest market research...
► Artikel lesen
20.12.18Orano: Industrial commissioning of the Philippe Coste plant at Tricastin104Regulatory News: The new Philippe Coste* conversion plant located at the Orano Tricastin site (Drôme) has now been successfully commissioned following the completion of its test program....
► Artikel lesen
20.12.18Global Truck Rental Market 2018-2022 | Industry Analysis and Forecast | Technavio99The global truck rental market research report by Technavio predicts the market to post a CAGR of more than 3% during the period 2018-2022. This press release features multimedia. View...
► Artikel lesen
20.12.18Total: Disclosure of Transactions in Own Shares85Regulatory News: In accordance with the authorization given by the combined ordinary and extraordinary shareholders' general meeting on June 1st, 2018 to trade on its shares and pursuant...
► Artikel lesen
20.12.18Mr. Dimitris Copelouzos Was Bestowed the Italian "Star of Order" ("Stella D' Italia") by the President of the Italian Republic352Mr. Dimitris Copelouzos, President of Copelouzos Group, was bestowed the "Italian Star of Order" ("STELLA D'ITALIA") with the title of "Knight" ("Cavaliere"), awarded by the President of...
► Artikel lesen
20.12.18Europcar Mobility Group: Tobias Zisik Appointed New Managing Director at Europcar Mobility Group in Spain186Regulatory News: Europcar Mobility Group (Paris:EUCAR) has announced today the appointment of Tobias Zisik as its new Managing Director for Spain, beginning his new role on January...
► Artikel lesen
20.12.18Disposal of Rémy Cointreau's Distribution Subsidiaries in the Czech Republic and Slovakia to Jägermeister447Regulatory News: The Rémy Cointreau Group (Paris:RCO) announces the signing of a share purchase agreement for the disposal of its distribution subsidiaries in the Czech Republic (Rémy...
► Artikel lesen
20.12.18OSE Immunotherapeutics Announces First Healthy Volunteers Dosed in Phase 1 Clinical Trial of OSE-12780Entry into clinical phase of this anti-IL-7 receptor antagonist A breakthrough approach for the treatment of inflammatory autoimmune diseases Regulatory News: OSE Immunotherapeutics...
► Artikel lesen
20.12.18Adocia Announces Its Financial Calendar For 2019134Regulatory News: Adocia (Euronext Paris: FR0011184241 ADOC) (Paris:ADOC), a clinical stage biopharmaceutical company focused on diabetes treatment and other metabolic diseases with...
► Artikel lesen
20.12.18Advicenne Publishes its Financial Calendar for 2019130Regulatory News: Advicenne (Paris:ADVIC) (Euronext: ADVIC), a specialty pharmaceutical company focused on the development of pediatric friendly therapeutics for the treatment of orphan...
► Artikel lesen
Seite:  Weiter >>